TP53 and breast carcinoma: Meanwhile, PRMT6 binds to the p21 promoter and suppresses p21 expression via H3R2me2a methylation, thereby inhibiting cell cycle arrest and senescence in a p53-independent manner and promoting breast cancer cell proliferation [315].